BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards. BIOCAD is one of the world`s few full-cycle drug development and manufacturing companies, from new molecule discovery and genetic engineering to large-scale commercial production and marketing support. BIOCAD`s medicines are dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.
View Top Employees from BIOCADWebsite | https://biocadglobal.com/ |
Revenue | $530.4 million |
Employees | 789 (561 on RocketReach) |
Founded | 2001 |
Address | 34-a Ul. Svyazi Strelna, Petrodvorets, St.-Petersburg 198515, RU |
Phone | +7 812 380-49-33 |
Technologies |
JavaScript,
HTML,
Twitter
+48 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceutical, Pharmaceuticals, Science and Engineering, Healthcare, Manufacturing, Web Development, Software |
Web Rank | 238402 |
Web Visits | 139700 |
Keywords | Genetic Testing, Cancer Treatment, Multiple Sclerosis, Drug Development And Manufacturing, Marketing Support |
SIC | SIC Code 28 Companies, SIC Code 873 Companies, SIC Code 87 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 5417 Companies |
Looking for a particular BIOCAD employee's phone or email?
The BIOCAD annual revenue was $530.4 million in 2024.
Natalia Chekulaeva is the Head of Purchasing Department of BIOCAD.
561 people are employed at BIOCAD.
BIOCAD is based in Petrodvorets, St.-Petersburg.
The NAICS codes for BIOCAD are [541713, 54171, 325, 54, 541, 32, 5417].
The SIC codes for BIOCAD are [28, 873, 87, 283].